Alessia Peter
Bellinzona, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses.
Journal: Nature communications
Published: February 10, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.
Journal: Journal of hepatology
Published: January 10, 2025
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness.
Journal: Antimicrobial agents and chemotherapy
Published: February 20, 2024
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 06, 2022
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
Journal: Science (New York, N.Y.)
Published: August 14, 2020
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Journal: Cell
Published: August 03, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibody.
Journal: bioRxiv : the preprint server for biology
Published: June 09, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
Journal: Nature
Published: April 06, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026